Press release
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Innovative Digital Treatment Device Shaping the Future of the Industry
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate (CAGR) of 4.7%. The surge during this historical era can be linked to factors such as escalated stress levels, widespread mental health disorders, irregular working schedules, heightened awareness and diagnosis, as well as a significant increase in the intake of stimulants.
How Will the Insomnia Market Size Evolve and Grow by 2029?
The insomnia market's projected growth looks robust in the years ahead. It is anticipated to expand to $6.62 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this uptick during the projected period include impacts from the global health crisis, heightened awareness around sleep hygiene, increased focus on mental health and wellness, government-led initiatives towards sleep health, and the influence of societal factors. Key trends during this period will be the adoption of digital health solutions for sleep tracking, the use of cognitive behavioral therapy for managing insomnia, a rise in telehealth for sleep consultations, the emphasis on integrating sleep health in primary care, and continued research into innovative therapeutic targets.
View the full report here:
https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report
What Drivers Are Propelling the Growth of Insomnia Market Forward?
Growth in the insomnia market is projected to be driven by a surge in work-related stress. Work-related stress is described as harmful emotional and physical reactions that occur when the job expectations and stressors are not compatible with the worker's resources, skills, or knowledge. Stress from work can result in poor health conditions, including insomnia. The intensity of insomnia determines whether patients are treated with medications or cognitive-behavioral therapies, and others. Hence, a rise in work-related stress is fueling market sales for insomnia. For example, the American Psychological Association stated in October 2022 that work-related stress continues to be a significant issue, with 77% of employees experiencing work-related stress within the past month. Further, 57% reported negative effects, such as emotional fatigue (31%), often associated with workplace burnout. As a result, the increase in work-related stress is promoting the expansion of the insomnia market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12120&type=smp
Which Emerging Trends Are Transforming the Insomnia Market in 2025?
Product innovation is becoming a notable trend in the insomnia market. Big players in the insomnia therapeutics market are focusing on creating innovative therapies to maintain their market standing. An example to note is WELT, a medical device firm based in Korea, which in April 2023, secured approval from the Ministry of Food and Drug Safety (MFDS) for its digital insomnia treatment instrument, WELT-I. WELT-I has been identified as an innovative medical tool aimed at addressing behavioral, psychological, and cognitive aspects that perpetuate or aggravate insomnia. The device facilitates treatment using cognitive-behavioral therapy (CBT), acknowledged as an initial treatment choice in clinical guidelines for insomnia management. The device is categorized as Software as a Medical Device (SaMD), which enhances sleep by providing personalized sleep durations, examining sleep disruption patterns, intervening in patient habits for improved sleep quality, and offering an eight-week relaxation therapy to alleviate tension and anxiety.
What Are the Key Segments in the Insomnia Market?
The insomnia market covered in this report is segmented -
1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy
2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy
2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12120&type=smp
Who Are the Key Players Shaping the Insomnia Market's Competitive Landscape?
Major companies operating in the insomnia market include Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.
What Geographic Markets Are Powering Growth in the Insomnia Market?
North America was the largest region in the insomnia market in 2024. The regions covered in the insomnia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12120
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Innovative Digital Treatment Device Shaping the Future of the Industry here
News-ID: 4100376 • Views: …
More Releases from The Business Research Company
Healthcare Robotics Market Report Provides Insights Into Market Evolution And Gr …
The healthcare robotics industry is on track for significant expansion as technological advancements and innovative applications continue to transform the sector. With AI integration and growing demand for more precise, efficient healthcare solutions, this market is set to experience robust growth in the coming years. Let's explore the projected market size, key players, notable trends, and the primary segments shaping this evolving industry.
Healthcare Robotics Market Size and Its Future Outlook…
Healthcare Quality Management Market Outlook Signals Expansion To $11.03 Billion …
The healthcare quality management market is gaining significant attention as healthcare providers seek smarter, more efficient ways to enhance patient care and compliance. Driven by technological advancements and shifting industry priorities, this market is set for substantial growth in the coming years. Here's an overview of its expected size, leading companies, emerging trends, and market segmentation.
Projected Growth and Market Size of Healthcare Quality Management
The healthcare quality management market…
Healthcare Payment Processing Market Report 2026 Market Outlook Supported By A F …
The healthcare payment processing sector is set to experience substantial growth as digital transformation reshapes the way payments are handled in the medical industry. With advancements in technology and increasing demand for streamlined financial transactions, this market is positioned to expand rapidly in the coming years. Here's an in-depth look at the market's size projections, leading players, emerging trends, and segmentation.
Projected Expansion of the Healthcare Payment Processing Market Through 2030…
Healthcare Mobility Solutions Market Insights Highlight Segment Expansion And Ma …
The healthcare mobility solutions sector is set to experience remarkable expansion over the next several years, driven by advancements in connected care and digital health technologies. As the demand for smarter, more integrated healthcare tools grows, this market is poised to transform how medical services are delivered and managed globally. Here's an in-depth look into the projected market size, key players, emerging trends, and segmentation within this vibrant industry.
Expected Growth…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
